知临集团（Aptorum Group Ltd）近日宣布，其旗下Diamir Biosciences与Instant Nanobiosensors（INB）达成战略合作，共同推进INB开发的自动化ApoE检测平台在阿尔茨海默病领域的验证工作。
此次合作旨在评估该平台在阿尔茨海默病早期筛查与诊断中的应用潜力。双方将整合资源，加速技术验证进程，为未来临床转化奠定基础。
这一举措标志着知临集团在神经退行性疾病诊断领域的战略布局进一步深化。通过合作，有望为阿尔茨海默病的早期干预提供更高效、精准的检测方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.